774 related articles for article (PubMed ID: 31022276)
1. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU
PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276
[TBL] [Abstract][Full Text] [Related]
2. Availability, prices and affordability of essential medicines for children: a cross-sectional survey in Jiangsu Province, China.
Sun X; Wei J; Yao Y; Chen Q; You D; Xu X; Dai J; Yao Y; Sheng J; Li X
BMJ Open; 2018 Oct; 8(10):e023646. PubMed ID: 30341137
[TBL] [Abstract][Full Text] [Related]
3. Impact of National Drug Pricing Policy 2018 on access to medicines in Lahore division, Pakistan: a pre-post survey study using WHO/HAI methodology.
Saeed A; Saeed H; Saleem Z; Yang C; Jiang M; Zhao M; Ji W; Aziz MM; Khan FU; Gillani AH; Atif N; Fang Y; Babar ZUD
BMJ Open; 2020 Oct; 10(10):e034720. PubMed ID: 33033079
[TBL] [Abstract][Full Text] [Related]
4. Availability, prices and affordability of selected essential medicines in Jordan: a national survey.
Alefan Q; Amairi R; Tawalbeh S
BMC Health Serv Res; 2018 Oct; 18(1):787. PubMed ID: 30340486
[TBL] [Abstract][Full Text] [Related]
5. Availability, prices and affordability of essential medicines: A cross-sectional survey in Hanam province, Vietnam.
Nguyen HTT; Dinh DX; Nguyen TD; Nguyen VM
PLoS One; 2021; 16(11):e0260142. PubMed ID: 34793554
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.
Osuafor NG; Ukwe CV; Okonta M
PLoS One; 2021; 16(8):e0255567. PubMed ID: 34383799
[TBL] [Abstract][Full Text] [Related]
7. Availability, prices and affordability of essential medicines in Zhejiang Province, China.
Dong Z; Tao Q; Yan B; Sun G
PLoS One; 2020; 15(11):e0241761. PubMed ID: 33232336
[TBL] [Abstract][Full Text] [Related]
8. Price, availability and affordability of medicines.
Mhlanga BS; Suleman F
Afr J Prim Health Care Fam Med; 2014 Jun; 6(1):E1-6. PubMed ID: 26245401
[TBL] [Abstract][Full Text] [Related]
9. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
Ewen M; Zweekhorst M; Regeer B; Laing R
PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
[TBL] [Abstract][Full Text] [Related]
10. WHO key access antibiotics price, availability and affordability in private sector pharmacies in Pakistan.
Saleem Z; Saeed H; Akbar Z; Saeed A; Khalid S; Farrukh L; Irfan A; Anam A; Hassali MA; Rasheed H; Babar ZU
Cost Eff Resour Alloc; 2021 Feb; 19(1):10. PubMed ID: 33593366
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Availability, Prices, and Affordability of Selected Essential Medicines in Balochistan, Pakistan.
Bibi M; Haq NU; Kareem A; Ullah H; Baloch N; Rehman G; Nasim A
Int J Public Health; 2022; 67():1604375. PubMed ID: 35872706
[No Abstract] [Full Text] [Related]
12. Access to paediatric essential medicines: a survey of prices, availability, affordability and price components in Shaanxi Province, China.
Wang X; Fang Y; Yang S; Jiang M; Yan K; Wu L; Lv B; Shen Q
PLoS One; 2014; 9(3):e90365. PubMed ID: 24595099
[TBL] [Abstract][Full Text] [Related]
13. Measuring access to medicines: a survey of prices, availability and affordability in Shaanxi province of China.
Jiang M; Yang S; Yan K; Liu J; Zhao J; Fang Y
PLoS One; 2013; 8(8):e70836. PubMed ID: 23936471
[TBL] [Abstract][Full Text] [Related]
14. Access to Essential Cardiovascular Medicines in Pakistan: A National Survey on the Availability, Price, and Affordability, Using WHO/HAI Methodology.
Saeed A; Saeed F; Saeed H; Saleem Z; Yang C; Chang J; Jiang M; Zhao M; Saqlain M; Ji W; Aziz MM; Lambojon K; Gillani AH; Hayat K; Gul S; Fang Y; Babar ZU
Front Pharmacol; 2020; 11():595008. PubMed ID: 33708114
[No Abstract] [Full Text] [Related]
15. Evaluating access to oral anti-diabetic medicines: A cross-sectional survey of prices, availability and affordability in Shaanxi Province, Western China.
Yang C; Hu S; Zhu Y; Zhu W; Li Z; Fang Y
PLoS One; 2019; 14(10):e0223769. PubMed ID: 31618273
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive survey of cancer medicines prices, availability and affordability in Ghana.
Ocran Mattila P; Biritwum RB; Babar ZU
PLoS One; 2023; 18(5):e0279817. PubMed ID: 37134123
[TBL] [Abstract][Full Text] [Related]
17. Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India.
Satheesh G; Sharma A; Puthean S; Ansil T P M; E J; Raj Mishra S; Unnikrishnan MK
Trop Med Int Health; 2020 Dec; 25(12):1467-1479. PubMed ID: 32959441
[TBL] [Abstract][Full Text] [Related]
18. Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology.
Sisay M; Amare F; Hagos B; Edessa D
J Pharm Policy Pract; 2021 Jul; 14(1):57. PubMed ID: 34225781
[TBL] [Abstract][Full Text] [Related]
19. Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon.
Abdel Rida N; Mohamed Ibrahim MI; Babar ZUD
BMC Health Serv Res; 2019 Dec; 19(1):973. PubMed ID: 31852546
[TBL] [Abstract][Full Text] [Related]
20. Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia.
Babar ZU; Ibrahim MI; Singh H; Bukahri NI; Creese A
PLoS Med; 2007 Mar; 4(3):e82. PubMed ID: 17388660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
